 |
|
|
| |
High Efficacy in Patients With Chronic Hepatitis C Virus (HCV) Genotype 1b Infection Treated with Elbasvir/Grazoprevir for 12 Weeks: An Integrated Analysis
|
| |
| |
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Zeuzem S1; Serfaty L2; Vierling JM3; Cheng W4; George J5; Sperl J6;
Strasser S7; Kumada H8; Hwang P9; Robertson M9; Wahl J9; Barr E9;
Talwani R9; Platt H9
1Goethe University Hospital, Frankfurt, Germany; 2Université Pierre & Marie Curie, Paris, France; 3Baylor College of Medicine, Baylor-St. Luke's Medical Center, Houston, TX, USA; 4Royal Perth Hospital, Perth, WA, Australia; 5University of Sydney, Sydney, NSW, Australia; 6Institut Klinické a Experimentální Medicíny (IKEM), Prague, Czech Republic; 7AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia; 8Department of Hepatology, Toranomon Hospital, Tokyo, Japan; 9Merck & Co., Inc., Kenilworth, NJ, USA.
|
| |
|
|
|
|
|
